Neuropsicofarmacología
![Foto de Neuropsicofarmacología](/img/uploaded/133B5DEFC4D194B6A12E03E329850F74.png)
![Foto de Instituto de Investigación Sanitaria Biodonostia](/img/noimage_org.png)
Instituto de Investigación Sanitaria Biodonostia
San Sebastián, EspañaPublicacions en col·laboració amb investigadors/es de Instituto de Investigación Sanitaria Biodonostia (4)
2023
-
Dysautonomia and small fiber neuropathy in post-COVID condition and Chronic Fatigue Syndrome
Journal of Translational Medicine, Vol. 21, Núm. 1
2022
-
Brain fog of post-COVID-19 condition and Chronic Fatigue Syndrome, same medical disorder?
Journal of Translational Medicine, Vol. 20, Núm. 1
2018
-
Therapeutic Drug Monitoring of Second-Generation Antipsychotics for the Estimation of Early Drug Effect in First-Episode Psychosis: A Cross-sectional Assessment
Therapeutic Drug Monitoring, Vol. 40, Núm. 2, pp. 257-267
2017
-
A Pilot Study of the Usefulness of a Single Olanzapine Plasma Concentration as an Indicator of Early Drug Effect in a Small Sample of First-Episode Psychosis Patients
Journal of Clinical Psychopharmacology, Vol. 37, Núm. 5, pp. 569-577